Lipo-chord Liquid
NDC Package 64578-0145-1
Package Information
Lipo-chord (aceticum ac, acetylsal ac, adrenocorticotrophin, alumina, arsenicum alb, borago, ceanothus, chelidonium maj, chionanthus, chloramphenicolum, chlorpromazinum, cholesterinum, cortisone aceticum, damiana, folliculinum, fumaricum ac, kali iod, lycopodium, nat sulphuricum, nux vom, oleum morrhuae, petroleum, phenacetinum, phosphoricum ac, phosphorus, plumb met, saccharum off, silicea, taraxacum, thyroidinum.) liquids is classified as a
Identification & Billing
Clinical Specifications
- ACETIC ACID 18 [hp_X]/59.1mL
- ASPIRIN 18 [hp_X]/59.1mL
- CORTICOTROPIN HUMAN 18 [hp_X]/59.1mL
- ALUMINUM OXIDE 18 [hp_X]/59.1mL
- ARSENIC TRIOXIDE 30 [hp_X]/59.1mL
- BORAGE 6 [hp_X]/59.1mL
- CEANOTHUS AMERICANUS LEAF 6 [hp_X]/59.1mL
- CHELIDONIUM MAJUS 12 [hp_X]/59.1mL
- CHIONANTHUS VIRGINICUS BARK 6 [hp_X]/59.1mL
- CHLORAMPHENICOL 18 [hp_X]/59.1mL
- CHLORPROMAZINE 18 [hp_X]/59.1mL
- CHOLESTEROL 12 [hp_X]/59.1mL
- CORTISONE ACETATE 18 [hp_X]/59.1mL
- TURNERA DIFFUSA LEAFY TWIG 12 [hp_X]/59.1mL
- ESTRONE 18 [hp_X]/59.1mL
- FUMARIC ACID 30 [hp_X]/59.1mL
- POTASSIUM IODIDE 30 [hp_X]/59.1mL
- LYCOPODIUM CLAVATUM SPORE 30 [hp_X]/59.1mL
- SODIUM SULFATE 30 [hp_X]/59.1mL
- STRYCHNOS NUX-VOMICA SEED 30 [hp_X]/59.1mL
- COD LIVER OIL 12 [hp_X]/59.1mL
- KEROSENE 18 [hp_X]/59.1mL
- PHENACETIN 18 [hp_X]/59.1mL
- PHOSPHORIC ACID 30 [hp_X]/59.1mL
- PHOSPHORUS 30 [hp_X]/59.1mL
- LEAD 30 [hp_X]/59.1mL
- SUCROSE 30 [hp_X]/59.1mL
- SILICON DIOXIDE 30 [hp_X]/59.1mL
- TARAXACUM OFFICINALE 4 [hp_X]/59.1mL
- THYROID, UNSPECIFIED 9 [hp_X]/59.1mL
- Allergens - [CS]
- Amphenicol-class Antibacterial - [EPC] (Established Pharmacologic Class)
- Amphenicols - [EXT]
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Phenothiazine - [EPC] (Established Pharmacologic Class)
- Phenothiazines - [CS]
- Plant Proteins - [CS]
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0145 - Lipo-chord
- 64578-0145-1 - 59.1 mL in 1 BOTTLE, DROPPER
- 64578-0145 - Lipo-chord
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0145-1 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Lipo-chord, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains acetic acid; aspirin; corticotropin human; aluminum oxide; arsenic trioxide; borage; ceanothus americanus leaf; chelidonium majus; chionanthus virginicus bark; chloramphenicol; chlorpromazine; cholesterol; cortisone acetate; turnera diffusa leafy twig; estrone; fumaric acid; potassium iodide; lycopodium clavatum spore; sodium sulfate; strychnos nux-vomica seed; cod liver oil; kerosene; phenacetin; phosphoric acid; phosphorus; lead; sucrose; silicon dioxide; taraxacum officinale; thyroid, unspecified as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on August 18, 2017. The current certification is valid through December 31, 2027.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578014501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.